OmniAb, Inc. (OABI)
4.87
-0.12
(-2.40%)
USD |
NASDAQ |
Oct 02, 16:00
4.86
-0.01
(-0.21%)
After-Hours: 20:00
OmniAb Cash from Operations (TTM) : -17.67M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.67M |
| March 31, 2026 | -25.50M |
| December 31, 2025 | -36.46M |
| September 30, 2025 | -34.65M |
| June 30, 2025 | -31.47M |
| March 31, 2025 | -38.50M |
| December 31, 2024 | -39.66M |
| September 30, 2024 | -44.91M |
| June 30, 2024 | -44.53M |
| March 31, 2024 | -42.37M |
| Date | Value |
|---|---|
| December 31, 2023 | 2.347M |
| September 30, 2023 | 4.325M |
| June 30, 2023 | 6.291M |
| March 31, 2023 | 12.46M |
| December 31, 2022 | -3.587M |
| September 30, 2022 | -1.150M |
| June 30, 2022 | 2.116M |
| March 31, 2022 | 5.968M |
| December 31, 2021 | -5.672M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| IQVIA Holdings, Inc. | 2.819B |
| Champions Oncology, Inc. | -5.564M |
| Medpace Holdings, Inc. | 752.66M |
| Charles River Laboratories International, Inc. | 582.15M |
| Avantor, Inc. | 597.00M |